CH625214A5 - - Google Patents

Download PDF

Info

Publication number
CH625214A5
CH625214A5 CH1278777A CH1278777A CH625214A5 CH 625214 A5 CH625214 A5 CH 625214A5 CH 1278777 A CH1278777 A CH 1278777A CH 1278777 A CH1278777 A CH 1278777A CH 625214 A5 CH625214 A5 CH 625214A5
Authority
CH
Switzerland
Prior art keywords
formula
oxo
pyrrolidine
ester
yield
Prior art date
Application number
CH1278777A
Other languages
English (en)
French (fr)
Inventor
Ludovic Dr Rodriguez
Lucien Dr Marchal
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of CH625214A5 publication Critical patent/CH625214A5/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Cephalosporin Compounds (AREA)
CH1278777A 1976-10-22 1977-10-20 CH625214A5 (e)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43934/76A GB1539817A (en) 1976-10-22 1976-10-22 N-substituted lactams

Publications (1)

Publication Number Publication Date
CH625214A5 true CH625214A5 (e) 1981-09-15

Family

ID=10431009

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1278777A CH625214A5 (e) 1976-10-22 1977-10-20

Country Status (27)

Country Link
US (1) US4162325A (e)
JP (1) JPS5839148B2 (e)
AT (1) AT352742B (e)
BE (1) BE859925A (e)
BG (1) BG28413A3 (e)
CA (1) CA1095040A (e)
CH (1) CH625214A5 (e)
CS (1) CS200231B2 (e)
CY (1) CY1037A (e)
DD (1) DD131930A5 (e)
DE (1) DE2747369A1 (e)
DK (1) DK461877A (e)
ES (1) ES463424A1 (e)
FI (1) FI66600C (e)
FR (1) FR2368474B1 (e)
GB (1) GB1539817A (e)
HK (1) HK2380A (e)
HU (1) HU174864B (e)
IL (1) IL53171A (e)
KE (1) KE3013A (e)
MY (1) MY8000264A (e)
NL (1) NL7711414A (e)
PL (1) PL110679B1 (e)
SE (1) SE425782B (e)
SU (2) SU805945A3 (e)
YU (1) YU251977A (e)
ZA (1) ZA776260B (e)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE27T1 (de) * 1978-05-08 1981-04-15 Ucb Sa Lactam-n-essigsaeuren und ihre amide, verfahren zu ihrer herstellung und heilmittel, die sie enthalten
EP0115473A3 (de) * 1983-01-27 1987-01-21 Ciba-Geigy Ag Substituierte Pyrrolidinonderivate und Verfahren zu ihrer Herstellung
FI840260A (fi) * 1983-01-27 1984-07-28 Ciba Geigy Ag Pyrrolidinonderivat och foerfarande foer deras framstaellning.
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
WO1990012005A1 (en) * 1989-04-13 1990-10-18 Japan Tobacco Inc. New amino acid derivatives having prolylendopeptidase inhibitor activity
US5206386A (en) * 1991-03-20 1993-04-27 Isp Investments Inc. Controlled release N-substituted pyrrolidone esters and process for the use thereof
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
CN114685342B (zh) * 2020-12-25 2024-05-10 长沙博源医疗科技有限公司 一种左乙拉西坦衍生物、免疫原、抗左乙拉西坦特异性抗体及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121723A (en) * 1955-11-02 1964-02-18 Sterling Drug Inc Lower alkyl n-(tertiary-amino-lower-alkyl) lower alkamates and quaternary ammonium salts thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
NL7407140A (nl) * 1974-03-07 1975-09-09 Jose Maria Espinos Taya En Jos Werkwijze voor de bereiding van een n-gesub- stitueerd pyrrolidon.
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins

Also Published As

Publication number Publication date
MY8000264A (en) 1980-12-31
DD131930A5 (de) 1978-08-09
FR2368474A1 (e) 1978-05-19
SE425782B (sv) 1982-11-08
NL7711414A (nl) 1978-04-25
YU251977A (en) 1983-01-21
HK2380A (en) 1980-01-25
PL110679B1 (en) 1980-07-31
SE7711667L (sv) 1978-04-23
FI66600C (fi) 1984-11-12
CS200231B2 (en) 1980-08-29
AT352742B (de) 1979-10-10
HU174864B (hu) 1980-03-28
FI773069A (fi) 1978-04-23
IL53171A (en) 1982-02-28
DE2747369C2 (e) 1987-11-12
ES463424A1 (es) 1978-07-16
ATA749677A (de) 1979-03-15
CA1095040A (en) 1981-02-03
BE859925A (fr) 1978-04-20
IL53171A0 (en) 1977-12-30
CY1037A (en) 1980-08-01
FR2368474B1 (fr) 1980-08-08
SU805945A3 (ru) 1981-02-15
DK461877A (da) 1978-04-23
KE3013A (en) 1980-02-01
PL201601A1 (pl) 1979-01-29
ZA776260B (en) 1978-07-26
FI66600B (fi) 1984-07-31
US4162325A (en) 1979-07-24
JPS5353649A (en) 1978-05-16
GB1539817A (en) 1979-02-07
SU937450A1 (ru) 1982-06-23
DE2747369A1 (de) 1978-04-27
JPS5839148B2 (ja) 1983-08-27
BG28413A3 (en) 1980-04-15

Similar Documents

Publication Publication Date Title
EP0162036B1 (fr) (S)-alpha-éthyl-2-oxo-1-pyrrolidineacétamide
EP0447285B1 (fr) Nouveaux dérivés à structure naphtalénique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
EP0506539B1 (fr) Amides alkyl hétérocycliques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
FR2500450A1 (fr) Nouveaux derives aminomethyl-5 oxazolidiniques, leur procede de preparation et leur application en therapeutique
CH645091A5 (fr) Derives de la glycinamide, leur preparation et compositions pharmaceutiques les contenant.
FR2487829A2 (fr) Nouveaux imino acides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2689124A1 (fr) Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2639636A1 (fr) Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
FR2680507A1 (fr) Nouvelles naphtylethylurees et naphtylethylthiourees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2663934A1 (fr) Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
EP0110781B1 (fr) (Amino-2 éthyl)-6 benzoxazolinones substituées, leur préparation et une composition pharmaceutique les contenant
EP0005689B1 (fr) Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
CH625214A5 (e)
CA1258040A (fr) 2-amino oxazolines et leur procede d'obtention
EP0007824B1 (fr) Nouveaux dérivés de benzofuranne, leur procédé de préparation et composition thérapeutiqueles contenant.
EP0239436B1 (fr) Nouveau dérivé tricyclique dénommé acide (chloro-3 méthyl-6 dioxo-5,5 dihydro-6, 11 dibenzo (c,f) thiazépine (1,2) yl-11 amino) -5 pentanoique, son procédé de préparation et les compositions pharmaceutiques qui le contiennent
FR2625678A1 (fr) Agents anorexigenes a base de n-(quinuclidin-3-yl)-benzamides ou thiobenzamides
FR2643634A1 (fr) Nouveaux derives benzoxazolinoniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
CH632999A5 (fr) (2-thio)urees 1,3-disubstituees.
KR910003711B1 (ko) 2-(n-피롤리디노)-3-이소부톡시-n-치환된 페닐-n-벤질-프로필아민의 제조방법
CH634311A5 (fr) Derives du benzo(d)thiazole, leur procede de preparation et leurs applications en therapeutique.
CH661271A5 (fr) Derives de piperazine et d'homopiperazine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant.
EP0022017B1 (fr) Nouveaux dérivés de benzoyl-2 nitro-4 anilides, leur préparation et leur application en tant que médicaments
CH658786A5 (fr) Medicaments qui contiennent d'alpha-(n-pyrrolyl)-acides ou de leurs sels ou esters.
FR2570695A1 (fr) Diphenylazomethines a chaine ramifiee ou cyclique, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
PL Patent ceased